- Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisCharles H Chesnut III
Osteoporosis Research Group, University of Washington, Seattle, Washington 98185, USA
J Bone Miner Res 19:1241-9. 2004..Significant reduction in incident vertebral fracture risk by 62% and 50%, respectively, was shown after 3 years. This is the first study to prospectively show antifracture efficacy for the intermittent administration of a bisphosphonate...
- Safety and tolerability of oral daily and intermittent ibandronate are not influenced by ageMark P Ettinger
Radiant Research and Regional Osteoporosis Center of South Florida, 2081 SE Ocean Boulevard, Stuart, FL, USA
J Rheumatol 32:1968-74. 2005..We investigated the effect of age on the safety profile of oral daily and intermittent ibandronate, with particular emphasis on the upper gastrointestinal (GI) safety profile of ibandronate...